Firefly Neuroscience Quote - AIFF

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.00

Bid

2.00

Offer

5.00

Volume

40,721

2.95 Day's Range 3.22

2.74 52 Week Range 9.00

Previous Close

2.93

Open

2.95

Last Trade

3.12

Last Trade Time

Average Volume (3m)

217,752

Financial Volume

US$ 125,445

VWAP

3.0806

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Company successfully listed on Nasdaq under the symbol “AIFF” Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative...

Form 8-K - Current report

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...

Form 4 - Statement of changes in beneficial ownership of securities

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on...

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...

Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2	-6.25	3.2	3.36	2.89	37342	3.04523785	CS
4	-0.38	-11.2426035503	3.38	3.7774	2.8501	66396	3.24342184	CS
12	-0.6	-16.6666666667	3.6	5.82	2.74	217752	3.92602762	CS
26	-4.63	-60.6815203145	7.63	9	2.74	192046	4.0840968	CS
52	-4.63	-60.6815203145	7.63	9	2.74	192046	4.0840968	CS
156	-4.63	-60.6815203145	7.63	9	2.74	192046	4.0840968	CS
260	-4.63	-60.6815203145	7.63	9	2.74	192046	4.0840968	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M